Back

Medscape, LLC

  • Castration
  • Prostatic Neoplasms

Advancing Personalized Care for Prostate Cancer: Patient-Centered Solutions for mHSPC and nmCRPC

The goal of this activity is for learners to become better able to tailor treatment for patients living with metastatic hormone-sensitive prostate cancer (mHSPC) and nonmetastatic castration-resistant prostate cancer (nmCRPC).

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1.25 credits

MOC types

ABIM — Medical KnowledgeUp to 1.25 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 1.25 credits
  • MOC · Up to 1.25 points
  • Commercial Support
  • Released
    Nov 12, 2025
  • Last day to claim credit
    Nov 13, 2026 5 weeks left